Every three seconds, someone in the world develops dementia. There are over 6 million people living with dementia in the U.S. and 57 million globally. These figures will only increase in the coming ...

A new WHO study finds that telemedicine initiatives improve psychological well-being and quality of life among patients with ...

A new companion to the GSA KAER Toolkit for Brain Health helps clinicians and caregivers promote brain health, detect cognitive changes early, and support adults with intellectual and developmental ...

A new predictive tool combining amyloid PET data with key clinical factors estimates an individual’s lifetime risk for mild ...

There are many reasons why a 79-year-old man might need to get an MRI scan of his brain, some benign, some more concerning.

Eisai and Biogen have announced UK MHRA approval for Leqembi for intravenous (IV) maintenance dosing to treat early Alzheimer ...

Mayo Clinic scientists have developed a new method to predict Alzheimer's risk decades before symptoms appear, using brain scans and genetics to estimate a 10-year likelihood.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

A landmark study can now calculate a person's lifelong risk of memory decline, finding that Alzheimer's biological processes ...

Alzheimer’s disease, a neurodegenerative disease, which slowly damages memory and thinking skills can now be predicted before ...